Final guidance on US FDA's expedited access plan for devices in FY 2015
This article was originally published in SRA
Executive Summary
Device companies interested in the US Food and Drug Administration's new voluntary program for faster evaluation of certain high-risk devices for unmet medical needs can hope to get a clearer picture of the initiative when the agency issues final guidance on this topic in fiscal year 20151.